← Leaderboards
Deverick John Anderson
Duke University
$19,714,457
Attributed
$19,714,457
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.7M · FY2011–25$10M$7.5M$5M$2.5M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$15,597,765 · 2
AHRQ$3,472,607 · 2
NIH$644,085 · 1
By mechanism
U54$15,597,765 · 2
R01$3,472,607 · 2
K23$644,085 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Henry F Chambers$93,384,193
- Vance G Fowler$95,483,666
- Lingchong You$13,458,703
- Keith S Kaye$4,209,806
- Joseph Heitman$44,576,851
Others in their field
Top investigators on “Antimicrobial Resistance”
- M Kariuki Njenga · Washington State University$56,426,595
- Henry F Chambers · Duke University$39,310,267
- Vance G Fowler · Duke University$37,941,890
- Marian Ewell · The Emmes Company, Llc$35,864,978
- Alon Singer · Helixbind, Inc.$35,221,195
- Herbert W Virgin · Washington University$34,945,365
Research focus
Antimicrobial ResistanceBedsBiobankBiologicalCareer DevelopmentCaringCenters For Disease Control And Prevention (U.S.)Cessation Of LifeCharacteristicsClinical DataClinical EpidemiologyClinical TreatmentCohortCommunitiesCommunity HospitalsCommunity SettingCostCyclophosphamideDatabasesData SetElectrophoresis, Gel, Pulsed-FieldEmployee StrikesEnrollmentAntimicrobial
Grant awards (23)
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events$599,947
U54 · FY2025 · CK · contact PI
An infection prevention dilemma: should we place patients with C. difficile colonization on contact precautions?$500,000
R01 · FY2025 · HS · contact PI
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events$599,867
U54 · FY2024 · CK · contact PI
An infection prevention dilemma: should we place patients with C. difficile colonization on contact precautions?$500,000
R01 · FY2024 · HS · contact PI
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events$1,583,624
U54 · FY2023 · CK · contact PI
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events$1,674,336
U54 · FY2022 · CK · contact PI
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events$1,306,689
U54 · FY2020 · CK · contact PI
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events$545,228
U54 · FY2020 · CK · contact PI
Duke-UNC Prevention Epicenter Program for Prevention of Healthcare-Associated Infections$600,000
U54 · FY2019 · CK · contact PI
Duke-UNC Prevention Epicenter Program for Prevention of Healthcare-Associated Infections$499,985
U54 · FY2019 · CK · contact PI
Prevention of Surgical Site Infection using Statistical Process Control Charts$491,292
R01 · FY2019 · HS · contact PI
Duke-UNC Prevention Epicenter Program for Prevention of Healthcare-Associated Infections$2,199,126
U54 · FY2018 · CK · contact PI
Prevention of Surgical Site Infection using Statistical Process Control Charts$493,284
R01 · FY2018 · HS · contact PI
Duke-UNC Prevention Epicenter Program for Prevention of Healthcare-Associated Infections$799,513
U54 · FY2017 · CK · contact PI
Prevention of Surgical Site Infection using Statistical Process Control Charts$494,253
R01 · FY2017 · HS · contact PI
Duke-UNC Prevention Epicenter Program for Prevention of Healthcare-Associated Infections$5,189,450
U54 · FY2016 · CK · contact PI
Prevention of Surgical Site Infection using Statistical Process Control Charts$496,299
R01 · FY2016 · HS · contact PI
Prevention of Surgical Site Infection using Statistical Process Control Charts$497,479
R01 · FY2015 · HS · contact PI
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi$128,817
K23 · FY2015 · AI · contact PI
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi$128,817
K23 · FY2014 · AI · contact PI
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi$128,817
K23 · FY2013 · AI · contact PI
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi$128,817
K23 · FY2012 · AI · contact PI
Clinical and Molecular Epidemiology of Multidrug-Resistant Organisms in a Communi$128,817
K23 · FY2011 · AI · contact PI